Back to search
FDAFDA · Food and drugs·Recall number D-0509-2026

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

Published May 6, 2026 · Recall initiated: April 7, 2026

Summary

FDA records drug Class III recall D-0509-2026, published May 6, 2026 and initiated April 7, 2026. Recalling firm: Water-Jel Technologies, LLC; Status: Ongoing; Reported quantity: 31,488 tubes; Lot: Lots: A5014, A5018, A5019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed PH Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Water-Jel Technologies, LLC
Distributor
Nationwide in the USA
Lot
Lots: A5014, A5018, A5019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950 recalled?

Yes. FDA published recall D-0509-2026 on May 6, 2026. Reported hazard: Failed PH Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter